Changeflow GovPing Healthcare & Life Sciences Trial of Labor After One Cesarean Section, Cros...
Routine Notice Added Final

Trial of Labor After One Cesarean Section, Cross-sectional Observational Study, Pescara 2015

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

ClinicalTrials.gov registry entry NCT07549971 documenting a 2015 cross-sectional observational study conducted at Pescara Hospital, Italy, examining trial of labor after cesarean (TOLAC) in women with a prior cesarean delivery. The study enrolled women after 34 weeks' gestation, comparing outcomes between those attempting vaginal birth after cesarean and those undergoing repeat elective cesarean. Patients were counseled on induction methods including mechanical induction, membrane rupture, and oxytocin infusion for prolonged gestation exceeding 41 weeks plus 3 days or specific medical indications.

“in 2015 a protocol for trail of labor after a single cesarean delivery was approved by medical committee of Pescara Hospital.”

NIH/NLM , verbatim from source
Published by NIH/NLM on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

This ClinicalTrials.gov entry records NCT07549971, a cross-sectional observational study performed at Pescara Hospital in 2015 evaluating trial of labor after a single cesarean delivery. The study protocol was approved by the hospital's medical committee and analyzed women at 34 or more weeks' gestation with a previous cesarean, excluding those with specific medical indications for repeat cesarean. Patients were counseled on labor induction approaches including mechanical induction, rupture of membranes, and oxytocin infusion for prolonged gestation beyond 41 weeks 3 days or medical indications such as gestational diabetes or hypertension. This registry entry provides retrospective documentation of study design and does not impose new regulatory requirements.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Trial of Labor After One Cesarean Section a Cross-sectional Study After Protocol Introduction

Observational NCT07549971 Kind: OBSERVATIONAL Apr 24, 2026

Abstract

in 2015 a protocol for trail of labor after a single cesarean delivery was approved by medical committee of Pescara Hospital. A database from outpatient clinic evaluated all women after 34 weeks' gestation with a previous cesarean delivery. Patients with a specific medical indication for cesarean delivery were skipped, whilst the others were recruited within repetitive elective cesarean delivery or trial of labor based on maternal request. Patients were couselled on the opportunity of having a mechanical induction/ rupture of membranes and subsequent oxytocin infusion if needed due to prolonged gestation (above 41 weeks plus 3 days) or medical indication to delivery (i.e. gestational diabetes, hypertension, SGA, etc.)

Conditions: Trial of Labor After Cesarean, Trial of Labor; Failure

Interventions: repetitive elective CD

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH/NLM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH/NLM
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07549971
Docket
NCT07549971

Who this affects

Applies to
Healthcare providers
Industry sector
6221 Hospitals & Health Systems
Activity scope
Clinical research Observational study
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!